Stevanato group reports second quarter 2023 financial results

Piombino dese, italy--(business wire)--stevanato group s.p.a. (nyse: stvn), a leading global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology, and life sciences industries, today announced its financial results for the second quarter of 2023. second quarter 2023 highlights (compared with the same period last year) second quarter revenue increased 9% to €255.3 million. revenue from high-value solutions increased to 33% of total revenue. d.
STVN Ratings Summary
STVN Quant Ranking